Positive News Coverage Somewhat Unlikely to Affect Nutraceutical Int'l (NUTR) Share Price
News coverage about Nutraceutical Int'l (NASDAQ:NUTR) has trended positive recently, according to Accern. The research group identifies positive and negative press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Nutraceutical Int'l earned a media sentiment score of 0.35 on Accern’s scale. Accern also gave media stories about the company an impact score of 45.2898723325509 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
Shares of Nutraceutical Int'l (NASDAQ:NUTR) opened at $41.80 on Friday. The company has a debt-to-equity ratio of 0.28, a current ratio of 4.40 and a quick ratio of 1.42. The company has a market cap of $386.52, a P/E ratio of 26.97 and a beta of 0.48. Nutraceutical Int'l has a 12-month low of $24.92 and a 12-month high of $42.45.
About Nutraceutical Int'l
Nutraceutical International Corporation is an integrated manufacturer, marketer, distributor and retailer of nutritional supplements and other natural products. The Company’s products include vitamins and minerals; herbs; specialty formulas; personal care products; liquid nutritional products; homeopathics; functional foods, and other products.
Receive News & Ratings for Nutraceutical Int'l Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutraceutical Int'l and related companies with MarketBeat.com's FREE daily email newsletter.